SCHEMBL11275588

SCHEMBL11275588

O=C(NNc1nncc(-c2ccccc2)n1)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
KDM4E B2RXH2 2/20 0.46
RAB9A P51151 6/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
NPC1 O15118 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GAA P10253 1/20 0.44
ADORA1 P30542 5/20 0.42
TP53 P04637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HTT P42858 2/20 0.39
POLB P06746 3/20 0.39
ADORA3 P0DMS8 2/20 0.38
IKBKB O14920 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 2/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11328978 0.82 ADORA1 (0.51) MAPTKDM4ERAB9AKMT2AMEN1
SCHEMBL11337094 0.74 ADORA1 (0.58) MAPTKDM4EGAAADORA1ADORA3
SCHEMBL11337620 0.74 ADORA1 (0.54) MAPTKDM4ERAB9AKMT2AMEN1
SCHEMBL11264204 0.73 MAPT (0.50) MAPTKDM4ERAB9AKMT2AMEN1
SCHEMBL11331847 0.73 P2RX7 (0.55) MAPTKDM4ERAB9AKMT2AMEN1
SCHEMBL11126066 0.70 MAPT (0.61) MAPTKDM4ERAB9AKMT2AMEN1
SCHEMBL19454785 0.70 TDP1 (0.61) MAPTKDM4ERAB9AKMT2AMEN1
SCHEMBL12015941 0.68 MAPT (0.51) MAPTKDM4ERAB9AKMT2AMEN1
SCHEMBL11537180 0.68 MAPT (0.48) MAPTKDM4ERAB9AKMT2AMEN1
SCHEMBL11275893 0.68 MEN1 (0.38) MAPTKDM4ERAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4157392-A HYPOTENSIVE AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS AND NERVOUS SYSTEM EFFECTS DIAMOND SHAMROCK CORPORATION (US) 1979-06-05 US claimed
US-4310551-A Pharmacologically active substituted 1,2,4-triazines DIAMOND SHAMROCK CORPORATION (US) 1982-01-12 US disclosed
US-4251527-A ANTIINFLAMMATORY AGENTS DIAMOND SHAMROCK CORPORATION (US) 1981-02-17 US disclosed
US-4157392-A HYPOTENSIVE AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS AND NERVOUS SYSTEM EFFECTS DIAMOND SHAMROCK CORPORATION (US) 1979-06-05 US disclosed